Pancreatic β-cell failure mediated by mTORC1 hyperactivity and autophagic impairment

Area of Science:

• Cell Biology
• Metabolic Disease Research
• Endocrinology

Background:

• Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) in pancreatic beta cells is often linked to increased metabolic load.
• While mTORC1 is crucial for beta cell compensatory mechanisms, it also suppresses autophagy, a key cellular degradation process.

Purpose of the Study:

• To investigate the consequences of chronic mTORC1 hyperactivation in beta cells.
• To elucidate the role of mTORC1 hyperactivation in beta cell failure using a specific mouse model.

Main Methods:

• Utilized a mouse model with beta cell-specific deletion of Tsc2 (βTsc2(-/-)) to induce mTORC1 hyperactivation.
• Analyzed beta cell mass, apoptosis, endoplasmic reticulum stress, autophagy markers (p62/SQSTM1), and mitochondrial function in the mouse model.

Main Results:

• Observed an initial increase in beta cell mass followed by a decline, leading to hyperglycemia in βTsc2(-/-) mice.
• Detected increased apoptosis, endoplasmic reticulum stress, and impaired autophagy (p62/SQSTM1 accumulation) in older βTsc2(-/-) mice.
• Found increased mitochondrial mass but impaired mitophagy, indicating mitochondrial dysfunction.

Conclusions:

• Beta cell autophagy impairment serves as a critical link between mTORC1 hyperactivation and mitochondrial dysfunction.
• This dysfunction likely contributes significantly to the development of beta cell failure.